Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.95 USD
Change Today +0.41 / 9.03%
Volume 3.3M
As of 7:40 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Preston S. Klassen M.D., M.H.S.

Head of Global Development and Executive Vice President, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
46$1,597,869
As of Fiscal Year 2014

Background*

Dr. Preston S. Klassen, M.D., M.H.S., has been an Executive Vice President and Head of Global Development at Orexigen Therapeutics, Inc. since February 2015 and served as its Senior Vice President of Product Development and Head of Global Contrave Program since November 2009. Dr. Klassen served as Head of Global Development and Senior Vice President at Orexigen Therapeutics, Inc. Dr. Klassen led the global development program for Contrave. Formerly the Therapeutic ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

2014-Present
Independent Director and Member of Nominating & Corporate Governance Committee

Education*

Master's Degree
Duke University
MD
University of Nebraska College of Medicine

Other Affiliations*

Annual Compensation*

Salary$379,250
Total Annual Compensation$379,250

Stock Options*

All Other Compensation$180
Exercisable Options1,020,871
Unexercisable Options511,129
Total Number of Options1,532,000

Total Compensation*

Total Annual Cash Compensation$557,678
Total Short Term Compensation$379,250
Other Long Term Compensation$180
Total Calculated Compensation$1,597,869
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $4.95 USD +0.41

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$746.8K
Seth H. Z. Fischer Chief Executive Officer, Chief Commercial Officer and Director
VIVUS Inc.
$650.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.